We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

MERCK lowered the top end of its full-year sales guidance after demand for its HPV vaccine fell for a second straight quarter ...

Pharmaceutical company Merck (NYSE: MRK) was another underperformer on the Dow last month. The stock fell steadily throughout ...

Pharmaceutical M&A came back with a bang during October, after a quiet September. Merck & Co (NYSE: MRK) and AbbVie (NYSE: ...

Vitamins and mineral supplements can help address nutritional deficiencies that commonly affect people who have Crohn’s disease. Here's what your doctor may recommend.

In a world increasingly driven by rising health consciousness and consumer awareness, understanding food labeling ... Senior ...

The global glucosamine supplement market is projected to grow from USD 583.6 million in 2023 to USD 932.7 million by 2033, expanding at a CAGR of 4.8%, according to Future Market Insights. The rising ...

Is India’s booming healthcare market part of your strategy, or are you overlooking a crucial opportunity? This is a question that U.S. healthcare companies should be pondering as India’s health and ...

Despite Merck & Co. homing in on approval for its ... Sanofi saw revenues for its consumer health arm, Opella, grow 7.9%. Earlier this week, Sanofi confirmed it had entered exclusive negotiations ...